Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-08-25
1976-07-06
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424341, 424356, A61K 31085, A61K 3109, A61K 31015
Patent
active
039682510
ABSTRACT:
A method of treating vascular thrombosis in Warm-blooded animals, employing an arylacetylene as the active antithrombotic agent.
REFERENCES:
patent: 3340308 (1967-09-01), Sterling et al.
patent: 3810944 (1974-05-01), Diamond et al.
patent: 3852364 (1974-12-01), Diamond
Lacefield William B.
Marshall Winston S.
Eli Lilly and Company
Maycock William E.
Moyer Donald B.
Smith Everet F.
LandOfFree
Arylacetylene compounds as antithrombotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylacetylene compounds as antithrombotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylacetylene compounds as antithrombotic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1534088